Qurient Co., Ltd. (KOSDAQ:115180)
26,050
+800 (3.17%)
At close: Aug 20, 2026
Qurient Market Cap
Qurient has a market cap or net worth of 1.06 trillion as of August 20, 2026. Its market cap has increased by 176.07% in one year.
Market Cap
1.06T
Enterprise Value
1.03T
Revenue
7.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
26,050.00
ChartMarket Cap Chart
Since February 29, 2016, Qurient's market cap has increased from 281.86B to 1.06T, an increase of 275.82%. That is a compound annual growth rate of 13.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.06T | -10.64% |
| Dec 30, 2025 | 1.19T | 674.51% |
| Dec 30, 2024 | 153.05B | 69.38% |
| Dec 28, 2023 | 90.36B | -24.77% |
| Dec 29, 2022 | 120.11B | -63.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 1.71T |
| JS Link | 1.28T |
| Rznomics | 1.03T |
| AprilBio | 584.57B |
| ROKIT Healthcare | 513.11B |
| Inventage Lab | 399.65B |
| Curocell | 382.20B |
| IntoCell | 332.74B |